Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
Maeda
H
H
Dept. of Surgery, Sakura National Hospital, Japan.
Sakamoto
K
K
Kashiwabara
H
H
Hachisu
T
T
Yamada
H
H
Matsushita
K
K
Yamada
K
K
Yokoyama
T
T
D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology; D006085:Graft Survival; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D006973:Hypertension / Q000150:complications / Q000453:epidemiology / Q000503:physiopathology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D012044:Regression Analysis; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine